Arizona State Retirement System’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,575
Closed -$47K 2082
2025
Q1
$47K Buy
27,575
+2,204
+9% +$8.27K ﹤0.01% 2080
2024
Q4
$128K Buy
25,371
+1,369
+6% +$6.77K ﹤0.01% 2046
2024
Q3
$131K Buy
+24,002
New +$158K ﹤0.01% 2065
2023
Q1
Sell
-15,986
Closed -$33.7K 2234
2022
Q4
$33.7K Buy
15,986
+591
+4% +$1.79K ﹤0.01% 2208
2022
Q3
$50K Buy
15,395
+42
+0.3% +$161 ﹤0.01% 2168
2022
Q2
$49K Buy
15,353
+1,431
+10% +$7.96K ﹤0.01% 2200
2022
Q1
$98K Buy
13,922
+60
+0.4% +$349 ﹤0.01% 2158
2021
Q4
$100K Buy
+13,862
New +$137K ﹤0.01% 2217

Other funds holding HUMA

Arizona State Retirement System's HUMA Position: Q2 2025 in Review

Arizona State Retirement System sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 27,575 shares — an estimated $47K sold.

Arizona State Retirement System first reported a position in HUMA in Q4 2021 and held it in 8 quarters. The position peaked at $131K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Arizona State Retirement System reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 27,575 Humacyte shares in Q2 2025, an estimated $47K.
  • Arizona State Retirement System first reported a position in Humacyte in Q4 2021 and held it in 8 quarters.
  • Arizona State Retirement System's Humacyte position peaked at $131K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Arizona State Retirement System's 13F filing for Q2 2025, filed 13 Aug 2025.